
The CLEARTEST Liquid Ecstasy Rapid Test is a qualitative in-vitro diagnostic test for the preliminary detection of gamma-hydroxybutyric acid (GHB) in liquids. The test system is designed for professional use and supports a timely assessment in cases of suspected drug use in security-relevant or preventative contexts.
The test is performed using a standardized procedure and requires no additional laboratory equipment. The result is visually assessable after approximately ten minutes and allows for an initial qualitative evaluation. The detection limit is 10 µg/ml. Depending on the time of exposure, GHB can be detected for up to approximately twelve hours after possible ingestion.
This rapid test is suitable for use in security measures, prevention strategies, and as a supplementary assessment in forensic investigations. It is not intended for self-testing and does not replace further analytical examinations. Store at room temperature. This product is intended exclusively for professional in-vitro diagnostic use.
Delivery information:
WEEE number:
Assistive device number:
Manufacturer:
Servoprax GmbH
Am Marienbusch 9
46485 Wesel